These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 18789655

  • 1. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS, Koh WJ, Kwon OJ, Cho SN, Shim TS.
    Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
    [No Abstract] [Full Text] [Related]

  • 2. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB, TBNET.
    J Antimicrob Chemother; 2009 Oct; 64(4):879-83; author reply 883-4. PubMed ID: 19651787
    [No Abstract] [Full Text] [Related]

  • 3. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW, Chang KC, Chau CH.
    J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract] [Full Text] [Related]

  • 4. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    Koh WJ, Shim TS.
    J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.
    Yew WW, Chau CH, Wen KH.
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):345-6. PubMed ID: 18284844
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB, Jiang RH, Li L, Xiao HP.
    Int J Tuberc Lung Dis; 2012 Mar; 16(3):358-63. PubMed ID: 22640450
    [Abstract] [Full Text] [Related]

  • 11. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ, Chu NH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY, Bilgin K, Uzun M, Durupinar B.
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
    Tangg SJ, Zhang Q, Zheng LH, Sun H, Gu J, Hao XH, Liu YD, Yao L, Xiao HP.
    Jpn J Infect Dis; 2011 Apr; 64(6):509-12. PubMed ID: 22116331
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B, Sandven P, Brubakk O.
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [Abstract] [Full Text] [Related]

  • 15. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM, SMIRA/TBNET Study Group.
    Clin Infect Dis; 2008 Mar 15; 46(6):958-9. PubMed ID: 18288911
    [No Abstract] [Full Text] [Related]

  • 16. Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis.
    Boutoille D, Grossi O, Depatureaux A, Tattevin P.
    Eur J Intern Med; 2009 Oct 15; 20(6):e134-5. PubMed ID: 19782904
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
    Singla R, Caminero JA, Jaiswal A, Singla N, Gupta S, Bali RK, Behera D.
    Eur Respir J; 2012 Apr 15; 39(4):956-62. PubMed ID: 21965225
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.